Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
Asad Bashey, Mary Eapen(Medical College of Wisconsin), Vanderson Rocha(Fundação Pró-Sangue Hemocentro de São Paulo), Mehdi Hamadani(Medical College of Wisconsin), Trevor Argall(Johns Hopkins Hospital), Rachel B. Salit(Johns Hopkins Hospital), Monzr M. Al Malki(City of Hope), Paul V. O’Donnell(Johns Hopkins Hospital), Pashna N. Munshi(Johns Hopkins Hospital), Claudio Anasetti(Moffitt Cancer Center), Scott D. Rowley(Johns Hopkins Hospital), Rizwan Romee(Washington University in St. Louis), Ephraim J. Fuchs(Johns Hopkins University), Robert J. Soiffer(Dana-Farber Cancer Institute), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Sameh Gaballa(Johns Hopkins Hospital), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Andrew St. Martin(Johns Hopkins Hospital), Ryotaro Nakamura(City Of Hope National Medical Center), Omotayo Fasan(Bristol-Myers Squibb (United States)), Stefan O. Ciurea(University of California, Irvine), Kavita Raj(Johns Hopkins Hospital), Mei-Jie Zhang(Medical College of Wisconsin), Melhem Solh(Johns Hopkins Hospital)
Cited by 325
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916